Brightgene Bio-medical Technology Co. Ltd. Class ASSE: 688166

Announcement on Receipt of SSE’s "Decision to Terminate the Review of the Private Placement Stock Issuance Application by BrightGene Bio-Medical Technology Co., Ltd."

· Issued by Brightgene Bio-medical Technology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Receipt of SSE’s "Decision to Terminate the Review of the Private Placement Stock Issuance Application by BrightGene Bio-Medical Technology Co., Ltd."

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis